Pathological Aβ accumulation may be a prerequisite for ERK1/2 pathway activation in OXYS rats; this accumulation in OXYS rats starts at age 7 months, i.e., at the stage of AD-like pathology manifestation [19]. This evidence concerns the gene MAPK3 and Alzheimer disease.